|
DHHS Healthcare Infection Control Practices Advisory Committee (HICPAC)
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This committee serves as the major policy advisory committee in the nation for healthcare epidemiology.
|
|
DHHS Medical Claims Review Panel
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
CC
|
The MCRP assists the DHHS in meeting its responsibility to provide quality health care in its facilities and by its practitioners. The MCRP reviews paid claims against DHHS facilities and providers to determine if the care provided met the standard of care and makes quality improvement recommendations to health care facilities and individual providers. The Panel meets monthly and includes two NIH representatives; the current Chair of the Panel is a NIH physician.
|
|
DHHS Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This steering committee is charged with developing a national action plan for addressing the important problem of healthcare-associated infections.
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, IHS, OS
|
NIDDK, CSR, NCATS, NCCIH, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
The DMICC facilitates cooperation, communication, and collaboration on diabetes among the participating government entities. DMICC meetings, held several times a year, help members identify emerging issues and opportunities and develop ways in which different government components can work together and build upon each other’s expertise and resources. This approach helps ensure that federal diabetes activities are coordinated and not duplicated, as well as stimulates collaborations where appropriate.
|
|
Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS)
|
Research Initiative
|
CDC, IHS
|
NIDDK, NCATS, NCI, NCMHD, NEI, NHLBI, NIA, NICHD
|
The Diabetes Prevention Program (DPP) showed that lifestyle change or metformin delay the development of type 2 diabetes. The Diabetes Prevention Program Outcomes Study is studying the long term effect of diet and exercise and the diabetes medication, metformin, on the delay of type 2 diabetes in participants of the DPP.
|
|
Diabetic Eye Disease Information Dissemination
|
Public Education Campaign
|
CDC
|
NEI
|
CDC''s National Diabetes Education Program is part of the National Eye Health Education Program Partnership. This past year, NEI and CDC worked outlets and conference calls, and circulated information in phConnect and among each other''s stakeholder groups.
|
|
Diabetic Retinopathy Clinical Research Network
|
Research Initiative
|
OS
|
NEI, NIDDK
|
The Diabetic Retinopathy Clinical Research Network (DRCR.net) is a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, diabetic macular edema and associated conditions. The DRCR.net supports the identification, design, and implementation of multicenter clinical research initiatives focused on diabetes-induced retinal disorders. Principal emphasis is placed on clinical trials, but epidemiologic outcomes and other research may be supported as well. The network is funded by the NEI, and co-funded by OS, through NIDDK, with the Special Funding Program for Type 1 Diabetes Research.
|
|
Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population
|
Research Initiative
|
CMS
|
CC
|
Centers for Medicare and Medicaid Services (CMS) and NIH CC Rehabilitation Medicine (RMD) agreed to collaborate in data-sharing for research, the results of which may be helpful to improve medical-service quality, utilization, and effectiveness for Medicare and Medicaid beneficiaries. CMS will provide electronic data to the NIH Clinical Center, which will perform analyses that are agreed to by both parties.
|
|
Diet-Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
NCI
|
The Food and Drug Administration (FDA) National Center for Toxicological Research and the National Cancer Institute (NCI) Division of Cancer Prevention, Nutritional Sciences Research Group are collaborating on an Interagency Agreement in which NCI will provide funds to examine the role of epigenetic mechanisms as factors that predetermine individual susceptibility to development of hepatocellular carcinoma and to provide evidence that epigenetic alterations may be used as markers of susceptibility to disease development and correction of those epigenetic abnormalities during hepatocarcinogenesis may be a crucial decisive factor in cancer prevention strategies.
|
|
Dietary Supplements Ingredient Database (DSID)
|
Research Initiative
|
CDC, FDA
|
OD/DPCPSI/ODP, NCI, NHLBI, NIDDK, OD/DPCPSI/ODS
|
The NIH Office of Dietary Supplements (ODS) leads this program, which provides a database of basic information about the nutrient content of selected ingredients in dietary supplements, compared to label-reported ingredient levels. ODS, with collaboration from USDA, develops and maintains this database of statistical estimates—based on chemical analysis—of the nutrient content of selected ingredients in dietary supplements, compared with label-reported ingredient levels. Currently the Dietary Supplements Ingredient Database (DSID) provides estimated levels of 18 vitamin and mineral ingredients derived from analytical data for 115 representative unspecified adult multivitamin/multimineral supplements (MVMs). Additional dietary supplement ingredients will be included in future releases of the database.
|